Top

Reactions Weekly

Published in:

01-03-2021 | Pneumonia | Case report

Nivolumab

Immune-mediated pneumonia, hypothyroidism and skin rash following off-label use: 4 case reports

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Rapposelli IG, et al. Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis. Cancers 13: 1-14, No. 2, 2 Jan 2021. Available from: URL: http://doi.org/10.3390/cancers13020213

Title: Nivolumab
Immune-mediated pneumonia, hypothyroidism and skin rash following off-label use: 4 case reports
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keywords: Pneumonia
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Hypothyroidism
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-92489-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nivolumab

Immune-mediated pneumonia, hypothyroidism and skin rash following off-label use: 4 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Ruxolitinib/sulfamethoxazole

Phenobarbital

Baclofen overdose

Guanfacine overdose

HPRA: potential emicizumab interference with blood coagulation tests

Chlorpromazine/fluphenazine